Pfizer trimming research plants after buying Wyeth

Tools

Story Published: Nov 9, 2009 at 10:15 AM PDT

By Associated Press

Pfizer trimming research plants after buying Wyeth

NEW YORK (AP) - The world's biggest drugmaker is closing six of its 20 research facilities, reorganizing others, and cutting the jobs of roughly 15 percent of its scientists and support staff.

The moves are part of Pfizer Inc.'s massive reorganization after buying drug and vaccine maker Wyeth just three and half weeks ago.

The executives heading the combined research operation tell The Associated Press exclusively that integrating and reorganizing the two companies' laboratories will boost research productivity and efficiency and save money as well.

That money will be poured into research on key diseases Pfizer is targeting, including Alzheimer's disease, cancer, pain and inflammation, diabetes and infectious diseases.

Affected employees are being notified today.

Current Weather

Icon
Current Temp 55.0 °F
Fair and Breezy
Video
More Weather

Upload directly from your mobile device.

Learn how

YouNews

This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

On Demand

Resources and info you need to prepare for the switch to DTV.

Stay Connected

Viewer Poll

Do you agree with the University of Oregon's decision to let Ernie Kent go?

  • Yes, we need a new coach for the new arena
  • No, he deserves a season in the new arena
  • Who is Ernie Kent?